Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma

NCT02504333 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Adenocarcinoma

Interventions

DRUG: nab-paclitaxel
DRUG: gemcitabine
DRUG: m-FOLFOX
DRUG: nab-paclitaxel
DRUG: gemcitabine

Sponsor

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)